Cruz CH, Quiroz RH, Guerrero MC, Ibarra VF, Ochoa GP

Language: English/Spanish
References: 31
Page: 273-279
PDF size: 74.81 Kb.

ABSTRACT

The aim of the present study was to determine the egg excretion and the optical density titre of F. hepatica through the ELISA test in cattle treated with triclabendazole every 56- and 112 days. Forty two animals divided into three groups of 14 animals each were used. Group A was treated every 56 days, Group B every 112 days, and Group C remained as the control one. Sedimentation egg count- and ELISA tests were used. In Group A, the frequency was reduced from 100% (day 0) to 0% (day 168), and average egg counts were reduced from 86.57 ± 10.5 (day 0) to 0 (day 168). In Group B, the frequency decreased from 100% (day 0) to 14.28% (day 168), and average egg counts were 82.85 ± 14 (day 0) to 0.85 ± 0.5 (day 168). In Group C, the prevalence was always of 100%, and average egg counts ranged from 68.14 to 78.85. Groups A and B showed statistical differences (P ‹ 0.05) on days 84, 112, 140 and 168, being always different to group C (P ‹ 0.01). Optical density titres were found under 0.679 nm. No statistical differences (P › 0.05) were found within the same group or among the three groups. The correlation between optical density titres and the egg excretion was low (0.26, 0.0022 and 0.011) for Groups A, B and C, respectively. It is concluded that the treatment with triclabendazole administered every 56 days significantly reduces (P ‹ 0.05) F. hepatica egg excretion in cattle when compared with that given every 112 days, and that the correlation between fecal egg-counts and optical densities was low.

REFERENCES

1. Castellanos HA, Escutia SJ, Quiroz RH. Frecuencia de fasciolasis hepática en bovinos sacrificados en plantas Tipo Inspección Federal en México de los años 1979-1987. Vet Méx 1992;23:339-342.

2. Quiroz RH. Impacto económico de la fasciolasis en rumiantes domésticos. En: Skewes H, editor. Sistema de Universidad Abierta (S U A). Compendio de producción bovina. México, D.F. Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México, México, 1993:1-4.

3. Rangel RJL. Estudio poblacional de la fasciolasis en el estado de Tabasco (tesis de doctorado). Villahermosa (Tab) México: Facultad de Biología. Universidad Juárez Autónoma de Tabasco, 1995.

4. Rapic D, Dzakula N, Richards RJ. Comparative efficacy of triclabendazole, nitroxinil, and rafoxanide against immature and mature Fasciola hepatica in naturally infected cattle. Vet Rec 1988;22:59-62.

5. Tello RM. Prevalencia anual de fasciolasis en bovinos de Tulancingo, Hidalgo, México (tesis de licenciatura). México (DF) México: Facultad de Medicina Veterinaria y Zootecnia. UNAM, 1991.

6. Malone JB, Craig MT. Cattle liver flukes: risk assessment and control. Comp Cont Educ Pract Vet 1990;12:747-754.

7. Pfister K. Serodiagnosis of fasciolosis in ruminant. Rev Sci Tech Off Int Epizoot 1990;9:511-518.

8. Dobbins SE. Comparison of the activity of some fasciolicides against immature liver fluke in calves. Vet Rec 1982;3:177-178.

9. Wamae LW. Fascioliasis as a limiting factor in livestock productivity. Bull Anim Hlth Prod South Afr 1991;39:257-269.

10. Quiroz RH. Principios diagnósticos de trematodos, cestodos, nematodos gastro- intestinales, pulmonares y filarias. Memorias del Curso-Taller Regional en Epidemiología, Diagnóstico y Control de Infecciones por Helmintos en Ganado; 1996 junio 15-19; México (DF). México (DF): Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México, 1996:143-152.

11. Boray JC. Chemotherapy of fasciolosis. New South Wales Vet Proc 1982;18:42-47.

12. Fuhui S, Bangia L, Chengui Q, Ming L, Mingbao F. The efficacy of triclabendazole (Fasinex) against immature and adult Fasciola hepatica in experimental infected cattle. Vet Parasitol 1989;33:117-124.

13. Quiroz RH, Ibarra VF, Vera MY. Eficacia del triclabendazol contra formas inmaduras de Fasciola hepatica y la ganancia de peso en bovinos. Vet Méx 1989;19:29-33.

14. Nuñez MTG, Quiroz RH. Efecto de tratamientos sistemáticos con nitroxinil en la reducción de huevos de Fasciola hepatica en ganado de lidia. Vet Méx 1994;25:341-343.

15. Ballesteros RG, Guerrero MC, Vega AN, Quiroz RH. Valoración del control de Fasciola hepatica en vacas tratadas con triclabendazol. Memorias del XIX Congreso Nacional de Buiatría. 1995 agosto 24-26; Torreón (Coahuila) México. México (DF): Asociación Mexicana de Médicos Veterinarios Especialistas en Bovinos, A.C., 1995:197-201.

16. García, E. Modificaciones al sistema de clasificación climática de Köppen. 2a ed. México (DF): Instituto de Geografía, Universidad Nacional Autónoma de México, 1973.

17. Quiroz RH. Parasitología y enfermedades parasitarias de los animales domésticos. México (DF): Limusa, 1996.

18. Boulard C, Bouvry M, Argente G. Comparaison de la détection des foyer de fasciolose par test ELISA sus lactoserum et sérum et par coproscopie. Ann Rech Vét 1985;16:363-368.

19. Ibarra F, Montenegro N, Vera Y, Boulard C, Quiroz H, Flores J, Ochoa P. Comparison of three ELISA tests for seroepidemiology of bovine fascioliosis. Vet Parasitol 1998; 77:229-236.

20. Smeal MG, Hall CA. The activity of triclabendazole against immature and adult Fasciola hepatica infection in sheep. Austr Vet J 1984;60:329-331.

21. Margolis L, Esch GW, Holmes JC, Kuris AM, Schad GA. The use of ecological terms in parasitology (report of an ad hoc committee of the American Society of Parasitologists. J Parasitol 1982;32:131-133.

22. Eckert J, Schneiter G, Wolf K. Fasinex (Triclabendazole)- ein neues Fazciolizide. Berl Münch Tierä rztl Wschr 1984;91:349-356.

23. Steel GD, Torrie JH. Bioestadística principios y procedimientos. México (DF): McGraw Hill, 1986.

24. SAS Institute. SAS/STAT. User’s guide. 4th ed. Cary (NC): SAS Institute Inc.,1990.

25. Ibarra VF, Quiroz RH, Vera MY, Tello RM. Determinación de la extensión del efecto del triclabendazol, rafoxanide, nitroxinil y meniclofolan en bovinos infectados en forma natural con Fasciola hepatica. Téc Pecu Méx 1987;25:404-407.

26. Bü scher G, Bowen FL, Strong MB, Allison JR, Richards RJ. Extension of the prepatent period of Fasciola hepatica in infected animals following treatment with triclabendazole. Vet Rec 1987;120:460-461.

27. Ibarra VF, Vera MY. Comparación del efecto extensivo de cinco fasciolicidas en bovinos en clima cálido. Vet Méx 1991;22:159-163.

28. McKellar QA, Kinabo LDB. The pharmacology of flukicidal drugs. Br Vet J 1991;147:306-321.

29. Malone JB. Fasciola hepatica: diagnosis, treatment programs and evaluation of economic losses. Memorias del Curso-Taller Regional en Epidemiología, Diagnóstico y Control de Infecciones por Helmintos en Ganado; 1996 junio 15-29; México (DF). México (DF): Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México, 1996:45-53.

30. Boray JC, Jackson R, Strong MB. Chemoprophylaxis of fasciolosis with triclabendazole. NZ Vet J 1985;33:182-185.

31. Echevarría FAM, Correa MBC, Wehrle RD, Correa IF. Experiments on anthelmintic control of Fasciola hepatica in Brazil. Vet Parasitol 1992;43:211-222.